The news comes amid concerning trends in U.S. alcohol consumption and associated health risks, including an alarming surge in alcohol-related hospitalizations and liver transplants in younger ...

The 7-2 opinion comes as companies push back against a yearslong federal regulatory crackdown on electronic cigarettes. It's ...

Over a median follow-up of 7 years, breast cancer survivors had an 8% lower risk of Alzheimer's dementia compared with ...

Benzodiazepines are useful in managing a variety of conditions, including anxiety, seizures, insomnia, and alcohol withdrawal ...

The FDA approved dupilumab (Dupixent) as the first targeted drug for bullous pemphigoid, a rare blistering skin disease that ...

The exact reasons for this increased risk are not entirely clear but may be associated with lower CD4 cell counts, increased viral loads, and an increased prevalence of smoking. Additionally, people ...

The FDA approved tafasitamab (Monjuvi) in combination with lenalidomide (Revlimid) and rituximab for relapsed or refractory follicular lymphoma. But the agency declined to expand the indication of ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

A federal court has temporarily blocked the Trump administration from clawing back millions in public health funding from four Democrat-led municipalities in GOP-governed states. It's the second such ...

Preoperative stereotactic radiotherapy (SRT) was just as safe as postoperative SRT for patients with resectable brain metastases. More patients treated with preoperative SRT completed both radiation ...